A

Axogen
D

AXGN

13.340
USD
0.22
(1.68%)
Market Closed
Volume
5,186
EPS
0
Div Yield
-
P/E
-40
Market Cap
587,070,175
OverviewSignalsIdeasNews
Related Instruments
    A
    ABMD
    0
    (0%)
    0.000000 USD
    A
    ALGN
    2.230
    (1.01%)
    223.930 USD
    BSX
    BSX
    -0.590
    (-0.67%)
    87.000 USD
    EW
    EW
    1.620
    (2.45%)
    67.780 USD
    ISRG
    ISRG
    -10.30
    (-1.92%)
    547.83 USD
    JNJ
    JNJ
    2.140
    (1.41%)
    155.14 USD
    MDT
    MDT
    1.520
    (1.77%)
    86.2 USD
    M
    MMSI
    0.620
    (0.61%)
    101.870 USD
    N
    NUVA
    -0.720
    (-1.77%)
    39.980 USD
    SYK
    SYK
    6.90
    (1.80%)
    384.88 USD
    TMO
    TMO
    -19.95
    (-3.74%)
    513.04 USD
    Z
    ZBH
    3.638
    (3.34%)
    112.490 USD
    More
News

Title: Axogen

Sector: Healthcare
Industry: Medical Devices
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.